BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22552503)

  • 21. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
    Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
    Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of stem-like cells in non-small cell lung cancer cells with specific peptides.
    Wang A; Chen L; Pu K; Zhu Y
    Cancer Lett; 2014 Aug; 351(1):100-7. PubMed ID: 24846302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Copies in T-Cell Malignancy 1 (MCT-1) Promotes the Stemness of Non-Small Cell Lung Cancer Cells via Activating Interleukin-6 (IL-6) Signaling through Suppressing MiR-34a Expression.
    Li Y; Wang B; Gui S; Ji J
    Med Sci Monit; 2019 Dec; 25():10198-10204. PubMed ID: 31891569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.
    Horiuchi S; Yamamoto N; Dewan MZ; Takahashi Y; Yamashita A; Yoshida T; Nowell MA; Richards PJ; Jones SA; Yamamoto N
    Int J Cancer; 2006 Aug; 119(4):823-30. PubMed ID: 16557588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells.
    Campard D; Vasse M; Rose-John S; Poyer F; Lamacz M; Vannier JP
    Stem Cells; 2006 May; 24(5):1302-14. PubMed ID: 16357344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.
    Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR
    Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
    Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
    Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
    Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
    Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Carcinogenesis; 2011 Jul; 32(7):1013-24. PubMed ID: 21515913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.
    Sun FF; Hu YH; Xiong LP; Tu XY; Zhao JH; Chen SS; Song J; Ye XQ
    Int J Clin Exp Pathol; 2015; 8(6):6287-300. PubMed ID: 26261505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
    Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
    Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
    Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N
    Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage.
    Prenissl N; Lokau J; Rose-John S; Haybaeck J; Garbers C
    Cytokine; 2019 Feb; 114():1-5. PubMed ID: 30557809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway.
    Srinual S; Chanvorachote P; Pongrakhananon V
    Int J Oncol; 2017 Apr; 50(4):1341-1351. PubMed ID: 28259926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.
    Levina V; Marrangoni A; Wang T; Parikh S; Su Y; Herberman R; Lokshin A; Gorelik E
    Cancer Res; 2010 Jan; 70(1):338-46. PubMed ID: 20028869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression.
    Suzuki M; Hashizume M; Yoshida H; Shiina M; Mihara M
    Cytokine; 2010 Aug; 51(2):178-83. PubMed ID: 20403707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).
    Garbers C; Kuck F; Aparicio-Siegmund S; Konzak K; Kessenbrock M; Sommerfeld A; Häussinger D; Lang PA; Brenner D; Mak TW; Rose-John S; Essmann F; Schulze-Osthoff K; Piekorz RP; Scheller J
    Cell Cycle; 2013 Nov; 12(21):3421-32. PubMed ID: 24047696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
    Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.